Iranian Anti-Cancer Medicine Extends Life, No Hair Loss
In a groundbreaking achievement in the field of oncology, Iran has introduced a pioneering anti-cancer medication that marks a significant shift in treatment approach. This innovative medicine enables patients to live longer while reducing the occurrence of adverse side effects. By leveraging targeted therapy, it precisely identifies and attacks cancer cells, thereby minimizing harm to surrounding healthy tissues. This remarkable breakthrough has the potential to significantly enhance the quality of life for cancer patients during their treatment journey.
The Technology Behind the Breakthrough
The innovative medicine, named Tederox, utilizes Antibody-ADCs technology, which enables targeted therapy to deliver medication directly to cancerous tissues. Owing to this combination of immunotherapy and chemotherapy results in higher efficacy while reducing the dosage needed for treatment.
According to Ali Aqajani, director of business development of a knowledge-based company, “This medicine can increase the life of cancerous patients manifold, and due to targeted therapy, we won’t have the common effects of cancer medicines like hair loss or weight loss.” With Tederox, breast cancer and digestive cancer patients can expect higher treatment effectiveness and fewer adverse effects.
Mass Production and Affordability
Iranian scientists have developed a groundbreaking anti-cancer medicine. This targeted therapy promises to revolutionize cancer treatment in the country. Researchers have successfully entered the mass production phase for this innovative drug. They’ve set prices at less than 10% of foreign brands, making it more accessible to patients. The imported version costs $3000, but the locally-produced alternative will be available for just $200. This homegrown solution offers hope for more affordable cancer treatment options in Iran.
Iran’s groundbreaking cancer treatment heralds a new era in oncology. Tederox, an Iranian anti-cancer medicine, employs targeted therapy to combat malignancies with remarkable precision. Consequently, patients may experience fewer adverse effects compared to traditional chemotherapy. This innovative drug boasts superior efficacy in battling various tumor types. Its current limited availability, the pharmaceutical company is poised to ramp up production.
Source: Pars Today